ELIZABETH MULLING: Open Payments
NPI 1801203716 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 30 payments from 11 companies in 2025. Trend: 2023 $798 · 2024 $897 · 2025 $532
Food & beverage: $516Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $158 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Exact Sciences Corporation | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| ABBVIE INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Abbott Laboratories | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
Products named: Ozempic, AIRSUPRA, Cologuard Collection Kit, Kerendia, SHINGRIX, QULIPTA, MOUNJARO, Rybelsus.
Industry payments across FL — which companies pay providers there.
